The differences between the Federal Circuit’s most-reversed and least-reversed district courts run far deeper than their success rates on appeal — a metric that can vary widely throughout the judiciary, according to Law360’s look at three years of Federal Circuit cases.
In a victory for Johnson & Johnson, the U.S. Court of Appeals for the Federal Circuit affirmed a lower court’s ruling preventing drug maker Mylan Laboratories Inc. from duplicating its lucrative anti-infective drug Levaquin.
After a six-year feud over a potential blockbuster drug, a small family-owned pharmaceutical company has been awarded $48 million from a biotechnology firm accused of illegally licensing its patents.
Electronics maker Honeywell International has filed another suit in its quest to protect its intellectual property covering LCD technology, this time targeting Citizen Watch Co.
Generic drug maker Mylan Laboratories and Johnson & Johnson subsidiary Alza have entered into an agreement over the rights to market a generic version of overactive bladder treatment Ditropan XL, adding more fuel to the fiery debate over authorized generics.
Extending the drawn-out legal row over generic Wellbutrin, a subsidiary of Andrx Pharmaceuticals LLC has sued British rival GlaxoSmithKline PLC, alleging the company’s current formula for the antidepressant infringes Andrx’s patent.
Pfizer's victory in the Lipitor trial may bring a chill to the generic drug industry, which has been increasingly bold in its legal maneuvers in recent years.
A judge has upheld the $213.9 million in damages awarded to Advanced Medical Optics Inc. in its patent infringement suit against Alcon Manufacturing, ruling also that the damages should be trebled and granting AMO attorney’s fees.
Electronic telecommunications exchange firm Arbinet-thexchange Inc. sued rival World-Link Telecom Inc. Monday, asserting its patents for electronic trading of telecommunications capacity.
Molecular diagnostics company Third Wave Technologies has scored another victory in its patent infringement suit against biotech company Stratagene after a judge tripled the damages previously awarded to Third Wave from $5.3 million to $15.9 million.
Blackberry maker Research In Motion Ltd. has reason to celebrate after the U.S. Patent and Trademark Office rejected claims within yet another patent being asserted by patent holding company NTP Inc.
A collective sigh of relief must have been audible at Pfizer’s headquarters on Friday, after the drug maker successfully fought off a gutsy patent challenge to the world’s best-selling drug.
The industry-wide battle over gaming patents continues to heat up, as two more companies have fired off lawsuits asserting patents that, given the growth of the gaming industry, could earn them billions.
Patent infringement lawsuits over digital music device iPod have now roped in companies that manufacture its accessories, with small technology companies hoping to win big off iPod’s market share.
Patent holder Forgent Network’s litigation campaign has paid off once again, with Yahoo Inc. settling a patent dispute over ubiquitous JPEG imaging technology.
A federal appeals court has granted telecommunications company Boston Communications Group’s emergency motion to stay an injunction that would have shut down its prepaid wireless service and cost the company up to 70% of its revenue.
Gibson, Dunn & Crutcher has hired seasoned litigator Josh Krevitt from Weil, Gotshal & Manges to join the firm’s New York office as co-chair of its national intellectual property practice group.
Electronics makers Sony Electronics and Command Audio Corp. have reached a settlement in their three-year battle over the patents for DVR technology, with Sony agreeing to pay royalties for use of Command Audio’s personal video recorder patents.
NTP Inc. has penned yet another licensing agreement with a wireless communications company, adding to the list of companies volunteering cooperation to head off any chance of litigation similar to NTP’s battle with Blackberry maker Research In Motion Inc.
Johnson & Johnson subsidiary Ethicon Endo-Surgery has accused a rival of reprocessing its single-use surgical scalpels and reselling them to hospitals without removing the Ethicon service mark, thereby infringing the company’s trademark.
Embattled Applera Corp. and MJ Research Inc. are in new settlement discussions, seeking to resolve their seven-year-old fight over valuable patents for polymerase chain reaction (PCR) instruments in the life sciences industry.